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Development of a filter to prevent
infections with spore-forming bacteria in
injecting drug users
Nour Alhusein1, Jenny Scott1, Barbara Kasprzyk-Hordern2 and Albert Bolhuis1*
Abstract
Background: In heroin injectors, there have been a number of outbreaks caused by spore-forming bacteria,
causing serious infections such as anthrax or botulism. These are, most likely, caused by injecting contaminated
heroin, and our aim was to develop a filter that efficiently removes these bacteria and is also likely to be acceptable
for use by people who inject drugs (i.e. quick, simple and not spoil the hit).
Methods: A prototype filter was designed and different filter membranes were tested to assess the volume of
liquid retained, filtration time and efficiency of the filter at removing bacterial spores. Binding of active ingredients
of heroin to different types of membrane filters was determined using a highly sensitive analytical chemistry
technique.
Results: Heroin samples that were tested contained up to 580 bacteria per gramme, with the majority being
Bacillus spp., which are spore-forming soil bacteria. To remove these bacteria, a prototype filter was designed to fit
insulin-type syringes, which are commonly used by people who inject drugs (PWIDs). Efficient filtration of heroin
samples was achieved by combining a prefilter to remove particles and a 0.22 μm filter to remove bacterial spores.
The most suitable membrane was polyethersulfone (PES). This membrane had the shortest filtration time while
efficiently removing bacterial spores. No or negligible amounts of active ingredients in heroin were retained by the
PES membrane.
Conclusions: This study successfully produced a prototype filter designed to filter bacterial spores from heroin
samples. Scaled up production could produce an effective harm reduction tool, especially during outbreaks such as
occurred in Europe in 2009/10 and 2012.
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Background
In Europe, there are around 1.3 million problem opioid
users, the majority of whom inject [1]. People who inject
drugs (PWIDs) frequently suffer from infections, in par-
ticular, skin and soft tissue infections, which are esti-
mated to cost the NHS in the UK up to £30 million
annually [2]. Since 2000, there have been, across Europe,
several outbreaks amongst PWIDs of particularly
serious, life threatening infections caused by brown her-
oin that is contaminated with bacteria such as Bacillus
and Clostridium, leading to severe skin and soft tissue
infections such as anthrax, wound botulism, gas gan-
grene and tetanus [3]. In 2000, there were 60 confirmed
cases of Clostridium novyi infection amongst PWIDs in
Scotland, with an 87% fatality rate [4], with further cases
reported across Europe. In 2009/10, there was a notable
outbreak with 119 cases of injectional anthrax; 19 deaths
were reported in the UK and Germany. Since then, fur-
ther cases and mortalities have been reported from
Germany, Denmark, UK and France [5]. Harm reduction
response during such outbreaks is at present limited,
with advice given usually limited to ‘switch to smoking,
do not inject’ [4]. An alternative solution could be to use
filters, but there are no filters available for heroin users
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that are easy to use and which can remove bacteria
(see also below). Driven by the realisation of the health
research community that no real solutions are provided
to deal with outbreaks of infections by spore-forming
bacteria, we decided to develop a filter that could be
distributed for use by PWIDs to prevent infections and
meet PWIDs’ acceptance criteria.
Bacillus and Clostridium species are commonly found
in soil, dust and human/animal faeces and are thought
to contaminate brown (base) heroin during production,
storage and transportation [6]. Characteristic of both
bacilli and clostridia is that, in the absence of nutrients,
they form dormant spores that are highly resistant to
stresses such as high temperatures, desiccation, UV
irradiation and chemical damage. As a consequence,
bacterial spores survive for long periods of time and only
germinate and develop into actively growing bacteria
again when conditions become favourable. One such
‘favourable’ condition is when spores are injected intra-
venously, intramuscularly or subcutaneously.
Many PWIDs filter their heroin before injection, but
this only removes particulates to prevent needle block-
age and, most likely, reduces small blood vessel damage.
Often, PWIDs use homemade pieces of material from
cotton wool or cigarettes; these are not sterile and could
be a further source of contamination [7]. Some needle
and syringe programmes supply filters, but even those
commercially available only remove particles (solid
materials found in brown heroin, e.g. from poppy straw)
that are larger than bacterial spores. The exclusion limit
of these filters is, at best, ~10 μm [8], whereas the aver-
age diameter of Bacillus anthracis (the causative agent
of anthrax) spores is ~0.8 μm [9]. Whether PWIDs use
supplied filters or homemade items, bacterial spores are
thus not removed and, if present, could lead to serious
and potentially lethal infections. The aforementioned
wheel filters are available with a pore size of 0.2 μm and
can thus remove bacterial spores, but these only fit sy-
ringes with detachable needles and cannot be used with
commonly used fixed needle syringes. In addition, these
wheel filters retain a significant amount of drug [10]
thus reducing the effect of the drug. Therefore, not all
PWIDs would find the use of such filters acceptable.
As mentioned above, the main cause of infections with
Bacillus and Clostridium species is contaminated heroin
[3–5, 11]. The ‘street’ process for preparing brown
heroin includes the use of acidic substrates such as citric
acid in water and flame heating [7]. These processes do
not destroy bacterial spores [12], and effective filtration
of heroin after acidification and heating could be a viable
option to remove spores. However, membranes with
pores small enough to remove bacterial spores are easily
blocked with particulates. Heroin that is prepared as
above still contains a lot of particulates which will block
membranes with small pores, making these not accept-
able for heroin users. Our aim was therefore to develop
a filtration device in which a prefilter removes particu-
lates, followed by a 0.2 μm filter to remove bacterial
spores. This device has to remove particulates and bac-
terial spores efficiently and be also acceptable to users.
Thus, it should not block due to particulates, retain no
or negligible volume of injection (or it would reduce the
hit so be unacceptable), have a fast filtration time and
also have minimal binding of the active ingredients in
heroin to the filter (again so as not to impact on effect).
In addition, it has to be easy to use. Unless the filter
device possesses all these qualities, it may not be accept-
able to PWIDs to incorporate such a device into their
drug preparation rituals.
Methods
Bioburden testing
To get an indication of the microbial contamination in
samples of heroin we obtained from the local police in
Bristol from several police seizures across the Avon and
Somerset constabulary area, the bioburden was deter-
mined using a plate-based method. In brief, 100 mg
samples of heroin were suspended in 1.5 mL phosphate
buffered saline (PBS), vortexed for 15 min and further
diluted tenfold. Fifty microlitres was plated on brain
heart infusion (BHI) agar (Oxoid) or Sabouraud agar
(Oxoid). To detect bacteria, the BHI agar plates were
incubated aerobically at 37 °C for 24 h or anaerobically
in a GasPak container (Becton Dickinson) at 37 °C for
up to 10 days. To detect fungi, Sabouraud agar plates
were incubated aerobically at 28 °C for 7 days. To iden-
tify microbial species, the 16 ribosomal RNA gene from
a number of colonies was amplified by the polymerase
chain reaction (PCR), using OneTaq polymerase (New
England Biolabs) and one of three oligonucleotide pairs
(for sequences of these oligonucleotides, see Additional
file 1 and References [13–15]). The bacterial species
were identified by sequencing the amplified products
and comparing these to the NCBI nucleotide database
(www.ncbi.nlm.nih.gov/nucleotide).
Heroin sample preparation
Heroin samples were prepared, with some minor modifi-
cations, following the method described, which is a
standard method for preparing brown heroin in Europe
[7, 10]. One hundred milligrams of brown heroin and
50 mg citric acid (Exchange Supplies Ltd.) was added to
0.7 mL water that was produced using a Milli-Q water
purification system (Millipore). This was heated in a Steri-
cup® (Apothicom, distributed by Exchange Supplies Ltd.)
until it just started to boil and became clear. The volume
of the solution was measured using a 1-mL insulin-type
syringe (Unisharp 1-mL fixed needle syringe; Exchange
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Supplies Ltd.), and to correct for evaporation, distilled
water was added to make the total volume of the sample
0.8 mL.
Filtration devices and membranes
Filtration of samples was performed with the following
filter devices: 25 mm Minisart RC25 syringe filters (0.2-
μm pore size, Sartorius), 15 mm Minisart RC15 (0.45-
μm pore size, Sartorius), 13 mm Millex GV (0.22-μm
pore size, Millipore) and 4 mm Millex GV (0.22-μm
pore size, Millipore) and a Swinnex filter holder (fitted
with a 13 mm membrane, Millipore). For the latter, we
tested all suitable types of membrane that were available
with the correct diameter and pore size (13-mm diameter,
0.22-μm pore size, all from Millipore): hydrophilic polyvi-
nylidene fluoride (PVDF), polytetrafluorethylene (PTFE),
mixed cellulose ester (MCE), polyethersulfone (PES) and
hydrophilic nylon. Where indicated, membranes were
combined with a glass fibre prefilter (13 mm in diameter,
2-μm pore size).
Determination of retention volume
To determine the retention (hold-up) volume of filtra-
tion devices, heroin samples were prepared as above,
and the volume of the solution was measured using a 1-
mL insulin-type syringe. After filtration, the volume was
measured again with a 1-mL syringe to determine the
loss in volume.
Binding of active ingredients in heroin to membranes
Heroin samples were prepared as above and the volume
of the solution was adjusted to 2 mL with distilled water.
The volume used was more than in a normal heroin
preparation, which could have increased solubility of
active ingredients, but the main aim here was to analyse
the effects on concentrations of active ingredients before
and after filtration through different types of mem-
branes. This was done by dividing each sample into two
aliquots; 1 mL was filtered and the other 1 mL was kept
unfiltered. Filtration was performed with Swinnex filter
holders and membranes listed above. In each case, the
assembly consisted of a prefilter with membrane, except
when the prefilter was tested on its own. Heroin samples
were diluted with distilled water/methanol (85:15 v/v) to a
final concentration of 800 ng/mL with the addition of an
internal standard (morphine-d3, 6-monoacetylmorphine-d3
and heroin-d9 at a concentration level of 10 ng/mL).
Heroin in samples was then quantified by liquid chroma-
tography coupled with tandem mass spectrometry) LC-
MS/MS using a Waters Acquity UPLC system and Waters
Xevo TQD triple quadrupole mass spectrometer with a
Chiralpak CBH HPLC column (5-μm particle size, 10 cm ×
2.0 mm; Chiral Technologies, France) as described [16].
Filtration of heroin samples with B. subtilis 168 spores
Bacterial spores of B. subtilis 168 [17] were harvested by
first growing overnight in Luria broth (LB; 1% tryptone,
0.5% yeast extract, 1% NaCl), diluting 100-fold in 50 mL
Schaeffer sporulation medium [18] and further growth
in a shaking incubator at 37 °C for 3 days. Next, the
spores were collected by centrifugation (5000g, 20 min),
re-suspended in 10 mL water and centrifuged again, re-
suspended in PBS and stored at 4 °C.
Heroin samples were prepared as above and B. subtilis
spores were added to a final concentration of ~108
spores/mL. These samples were filtrated, and the flow-
through was plated on LB agar plates for enumeration.
Manufacturing of filtration device
The filtration device was made from machine-grade
polycarbonate (Durbin Metal Industries), manufactured
using standard machine tools. The two main parts
(syringe holder and the filter collar) were screwed to-
gether. A butyl rubber O-ring was used around the syringe
port to prevent the air leakage (the O-ring).
Results
Bioburden testing
A critical factor in sterilisation of products such as drugs
or food is the bioburden, i.e. the number of microbes
contaminating the product. The higher the bioburden,
the greater the chance that some viable microbes are still
present after a sterilisation process. It is thus important
to know the bioburden before any process of removing
or killing microbes is employed. A number of studies
have shown that 90–95% of heroin samples are contami-
nated with bacteria (mainly bacilli) without reporting the
bioburden (see [6]), while only one study reported
bioburdens, which were found in the range of 1.6 × 102–
3.7 × 104 organisms per gramme heroin [19]. There may,
however, be significant differences depending on the ori-
gin of the heroin, and we therefore tested the bioburden
of the heroin samples we obtained. Samples were plated
on agar plates and then incubated to detect bacteria
(BHI agar plates) or fungi (Sabouraud agar). From this,
we found that the heroin contained up to 580 bacteria
per gramme of heroin. Obligate anaerobic organisms,
which includes Clostridium spp., were not found, and
also, no fungal contaminants were isolated.
Gram staining of 20 bacterial colonies from the BHI
agar plates showed that all were Gram-positive, with one
being coccoid and the remainder rod-shaped. From these,
11 colonies were identified to the species level, using the
commonly used method of sequencing of the 16rRNA
gene and comparing this to known sequences in a nu-
cleotide database. The rod-shaped bacteria were all
identified as Bacillus species: three colonies were iden-
tified as B. licheniformis, two as B. pumilus, two as B.
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subtilis, one as B. thermolactis and one as B. massilio-
senegalensis. The coccoid organism isolated was identi-
fied as Staphylococcus hominis.
Testing existing filtration devices
In order to remove bacteria (including spores) from her-
oin, filtration would be the only method that is practical,
as the heating of heroin during its preparation does not
kill bacterial spores (see below and Ref [12]). PWIDs
would not want drug losses due to filtration; if a signifi-
cant amount of drug remained in the filter, users would
be tempted to extract drug from those filters. A case in
point is the use of cotton pellets by heroin users, which
in some cases are handled with unwashed hands, stored
and re-used to recover any remaining heroin [10]. That
is an unsafe practise, as storage of wet filters can lead to
growth of microbes and increase risks of infections.
We first tested loss of filtration of heroin samples
using existing syringe filters that are available for labora-
tory research. This included standard syringe filters with
different diameters (4 mm, 13 mm, 15 mm and 25 mm)
and a Swinnex filter housing which allows for assembly
of the filter casing with a 13 mm membrane of choice.
In case of the filters with membrane diameters of 13-
25 mm, losses ranged from 7.5% (13 mm Millex GV
filter) to 44% (Minisart RC25 (25 mm) filter (Fig. 1). In
these cases, the losses were due to some of the heroin
being left in the filter housing, thus representing the
retention (hold-up) volume. In case of the 4 mm Millex
GV filter, it was not possible to filter the sample as the
filter immediately blocked up due to the presence of
particulates in the heroin. It should be noted that other
brands of syringe filters are available (in particular in the
range of 25–30 mm), but we did not test differences
between brands.
Effect of membrane filters on active ingredients in heroin
In addition to minimising losses due to the retention
volume, it is also important that the active ingredients in
heroin are not lost by binding to the membrane. To
analyse this, we firstly determined the main active ingre-
dients in the heroin samples, using a highly sensitive
analytical chemistry (LC-MS/MS) technique. The main
active ingredients were diamorphine (DIM 82.2%) and
6-monoacetylmorphine (6-MAM 17.6%), with a small
amount of morphine being present (0.2%). Next, we
determined the amount of these ingredients before and
after filtration through six types of membranes (PTFE,
PES, MCE, nylon, PVDF and glass fibre prefilter) that
were assembled in a Swinnex filtration device. Filtration
with most of the membranes showed little or no loss of
active ingredients (Fig. 2). An exception was the MCE,
which exhibited an average loss of ~25% of the active
ingredients. Removal of active ingredients would not be
acceptable for PWIDs, and MCE is therefore not suitable
for filtration of heroin.
Design of a novel filter
In the design of a filter for PWIDs, there were two im-
portant requirements: the loss of drug by filtration
should be low, and the device should be easy to use. As
shown above, the Millex GV filter, with a 13 mm mem-
brane, had the lowest retention volume. It would be ex-
pected that this volume would be less with a 4 mm
membrane, but this was unusable as the filter blocked
up immediately. This blocking up could be prevented by
filtrating with a 2 μm glass fibre prefilter before filtration
through the bacterial filter. This was achieved by cutting
Fig. 1 Evaluating the loss of volume in a 0.8 mL heroin sample by
filtration using commercially available syringe filters. The Swinnex
filter holder was fitted with a 13 mm PVDF membrane. The top
panel shows an image of the filters used, with the corresponding
data on the loss of volume from these filters in the graph below
Fig. 2 The percentage of active ingredients after filtration using
different membrane filters (n = 3). For all ingredients, the amount
before filtration was normalised to 100%
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a prefilter to the required size and adding this to a
4 mm syringe filter. The retention volume was not deter-
mined in this case, as cutting the prefilter was not very
accurate, leading to variability in the effectiveness of the
filter. Nevertheless, it does show that removing larger
particles before filtration through a 0.2 μm membrane
improves the flow properties.
On the second requirement, ease-of-use, syringe filters
do not perform particularly well. Standard syringe filters
are normally driven by positive pressure, i.e. a solution is
pushed through the filter with the aid of a syringe. The
filtrate needs to be collected in a sterile container and
then drawn up in a second sterile syringe before it is
ready for injection. A faster alternative method is to
draw the heroin into the syringe through a filter, using
the negative pressure generated by the syringe, which
reduces the number of steps. However, the syringe filters
that we tested, as well as most other syringe filters, are
not designed to work in reverse flow. And whichever
direction of flow is used, standard syringe filters do not
fit syringes with a fixed needle, which are commonly
used by PWIDs
Taking the above in consideration, we had two main
requirements in the design of a prototype filter. Firstly, it
should have good flow properties so that it can be used in
reverse flow, and secondly, the filtration device should be
able to accommodate syringes with a fixed needle to
minimise the number of steps required for injecting drugs.
A prototype device was made from polycarbonate (Fig. 3),
using machine tooling in the local workshop at the
University of Bath. The two main parts are the syringe
holder (part 2) and filter inlet (part 4), which fit together
with a screw thread. The syringe (with fixed needle) fits in
the syringe holder with the needle slotted in the needle
collar (part 3). To ensure an air-tight fit of the syringe in
the device, a butyl rubber O-ring was fitted (part 1) as
indicated. To prevent blocking of filter by particulates, a
2 μm glass fibre prefilter was combined with a 0.2 μm
filter in the device (both 13-mm diameter). The prefilter
and membrane are held together in a fixed position by the
membrane plate (part 5).
Filtration time of the prototype filtration device
We assembled inside the prototype filter the glass micro-
fibre prefilter with different 0.2 μm membrane filters to
test which combination showed the best flow properties.
The filters tested were PVDF, PTFE, MCE, PES and nylon.
With those, we tested the time it takes to filtrate a typical
heroin sample of 0.7 mL. This measure is not necessarily
an indication of the most efficient filtration of heroin, but
an overly long filtration process would not be acceptable
to PWIDs. The filtration time of heroin using a small
cotton pellet that is provided with a Stericup® pack that
the drug users frequently use is around 30 s. Our data
showed that filtration through MCE and PES membranes
was the fastest, taking around 50 s (Fig. 4). This was
slower than filtration through the cotton pellet, but that is
not surprising considering the difference in pore size.
Filtration through the other membranes was even slower,
with filtration times up to twice as long, indicating that
physical and chemical characteristics of the polymer used
in the membrane also play an important role in the rate of
flow. As our requirement was fast flow and low binding of
active ingredients, further tests were performed with PES
membranes only.
Fig. 3 Filtration device. a Schematic overview of the prototype
filtration device, which is assembled from five parts: (1) butyl rubber
O-ring, (2) syringe holder, (3) needle collar, (4) filter inlet and (5)
membrane plate. The prefilter and membrane are two separate parts
that are pressed together by the membrane plate. b Image of the
three main components of the filtration device; from left to right the
syringe holder, membrane plate and filter collar. c Image of filtration
device with a fixed needle syringe
Fig. 4 Filtration time of 0.7 mL of heroin using different membranes.
All membranes were combined with a prefilter in the prototype
filtration device
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Removal of bacterial spores using the prototype filtration
device
We tested the capability of removing bacterial spores
from heroin with the prototype filtration device and a
PES membrane. To this purpose, a 0.8 mL heroin
sample was spiked with B. subtilis spores (~108 spores),
followed by filtration. After this, samples were tested for
contamination with B. subtilis spores by plating on agar
plates and incubation at 37 °C. No growth was observed
after filtration, demonstrating that the filtration device
removed bacterial spores efficiently.
During preparation, heroin is heated in the presence
of acid to aid dissolution. Directly after preparation, we
measured the temperature to be 70 ± 5 °C (n = 3), which
cools down to 30 ± 2 °C in 4 min. We tested whether
filtration of heroin that was still hot would affect filtra-
tion, e.g. by damaging the membrane or enlarging the
pore size due to the increased temperature. To test this,
heroin samples spiked with B. subtilis spores were heated
to 75 °C and then filtrated either immediately or after
10 min of cooling. In both cases, no spores passed through
the filter device, showing that temperature of the heroin
does not affect the performance of the PES membrane.
Notably, heating in the presence of acid and heroin does
not affect viability of B. subtilis spores to a great extent; we
observed a survival of spores of 57% (+/−8%) after heating
B. subtilis spores in the standard heroin preparation. These
survival rates may not be the same for spores from other
bacteria, but a previous study also showed that C. novyi
spores survive the heroin preparation process [12].
Reusability
The prototype filter was tested as well to find out whether
it can be re-used, as this is something that should be dis-
couraged due to sharing risks. After using the filter once,
a second heroin sample was prepared, and the same filter
was used again. We found that the filtration process was
not efficient; out of 770 μL heroin sample before filtration,
only 100 μL passed through the filter into the syringe.
This is due to a layer of particles (filter bed) that formed
on the filter membrane during the first filtration process,
thus leading to blockage of the device for further use.
Thus, the prototype would discourage sharing and reuse.
It should be noted that there may be variation in batches
of heroin and preparation procedures by PWIDs; reusabil-
ity with such varying conditions was not tested by us.
Discussion
Heroin contaminated with bacteria may lead to out-
breaks of infectious diseases. The majority of the bac-
teria identified in brown heroin that we obtained from
the local police were Bacillus spp., which are sporulating
bacteria that are normally found in soil. It is not surpris-
ing that mainly sporulating bacteria were found, as
production of heroin from opium involves several steps
that require heating and treatment with various chemicals
[20], and only the very resistant bacterial spores could sur-
vive these chemicals. None of the bacteria we identified
were known to cause disease although it cannot be ex-
cluded that they would become pathogenic when injected.
Nevertheless, it seems quite likely that only occasional
batches with heroin are contaminated with true pathogens
such as B. anthracis or Clostridium species. One colony
was identified as S. hominis; this is a non-sporulating bac-
terium that is commonly found on skin and it probably
contaminated the heroin after production, e.g. during
packaging.
The number of bacteria found in the heroin that we
obtained was ~580 bacteria per gramme, which is within
the range that was published before [19]. This does not
seem a particularly high number, but it should be noted
that only a few spores are needed to cause an anthrax
infection [21]. Additionally, many PWIDs have poor
physical health, which may increase the probability of
getting an infection.
Current options for PWIDs to filter heroin include the
use of homemade filters from cigarette filters or cotton
pellets or purpose-made filters provided by pharmacies or
harm reduction programmes (e.g. Sterifilt®, produced by
Apothicom) that remove particulates from heroin [7, 8, 10].
These do not remove bacterial contamination [7, 8], but
here, we show a prototype filtration device that we devel-
oped, a viable option for the removal of bacterial spores
and particulates from heroin. Based on both flow properties
and low binding of active ingredients of heroin, a prefilter
combined with a PES membrane proved to be the most
efficient combination. The prefilter removes particulates
from the heroin, thereby preventing blocking of the 0.2 μm
filter capable of removing bacterial spores. Effectiveness of
removal of bacterial spores was tested with spores from B.
subtilis, which is a non-pathogenic relative of B. anthracis
(and is thus much safer to work with), with spores that are
smaller than those of most other sporulating bacteria,
including B. anthracis [9]. Thus, a filter designed to work
with B. subtilis spores will thus also efficiently remove
spores from most bacterial species.
A limitation of our study was that experiments were
performed with heroin prepared in a standardised man-
ner. However, there can be considerable variation between
both batches of heroin (e.g. different cutting agents) and
heroin users’ practise; such variations were not tested in
our laboratory setting.
The prototype filtration device was designed in such a
way that it would accommodate syringes with fixed
needles, such as insulin-type syringes. That would allow
for the preparation of heroin in a simple step by directly
drawing up heroin through the filter into the syringe,
similar to practises currently used by PWIDs who use
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products such as Sterifilt® filters [7]. Due to limitations
of the tooling equipment used, the device we designed is
rather bulky, but the prototype can be made significantly
smaller and consisting of fewer parts when it is manu-
factured by moulding instead.
We demonstrated that the prototype filter is effectively
‘single use’ because it blocks on reuse, so it could poten-
tially discourage reuse and sharing. This has advantages
for PWIDs in terms of reducing health risks. We also
showed that the prototype filter does not retain any
significant amounts of drug for a standardised heroin
sample, and therefore, there is no motive to save them for
‘bashing down’ at a later date when no drug or money is
available. This feature may of course make it unacceptable
to some PWIDs, who could find this a daunting prospect.
We envisage that after user acceptability testing and suit-
able production scale-up, our filter could form the corner-
stone of infection prevention during anthrax or other
spore-forming bacteria outbreak amongst PWID. It could
be distributed through Needle and Syringe Programmes
(NSPs) at the first detection of an outbreak or ideally
supplied continuously. If used for every injection, it would
make the use of sterile water (used by some PWIDs) less
of a necessity, as any microbes and particles, e.g. from tap
water, would also be removed during filtration.
Conclusions
Infections in PWIDs are common, with one potential
source of bacterial pathogens being the heroin itself.
There have been several outbreaks of infections by spore-
forming bacteria in PWIDs, resulting in high morbidity
and mortality. It is thus important to test and develop
filtration devices which can remove bacterial spores and
prevent such outbreaks. In this paper, a filtration device
was developed which removes bacteria and particulates, is
potentially easy for PWIDs to use and does not collect
active ingredients, thus does not reduce the ‘high’. A
future version needs to be streamlined, as the prototype is
too bulky and its manufacture would be expensive. Such
an improved device could be provided to attract PWIDs
to existing injecting equipment programmes (IEPs) across
Europe and beyond, especially during an outbreak of
anthrax or other spore-forming bacterial infections. The
overall aim of our filter is to reduce the health impact of
injecting drug use and save healthcare costs.
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